Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis

Caroline R. Morris, Eva A. Hurst

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


BACKGROUNDExtramammary Paget's disease (EMPD) is a rare malignancy with unclear pathophysiology that occurs predominantly on apocrine-rich skin. Surgery is the treatment of choice; however, procedures tend to be extensive and associated with a high rate of recurrence.OBJECTIVETo review the current literature on EMPD regarding treatment and prognosis.MATERIALS AND METHODSLiterature review using PubMed search for articles related to EMPD.RESULTSExtramammary Paget's disease classically presents as a slowly growing red plaque, which often mimics an inflammatory condition leading to significant delay in diagnosis. Diagnosis requires histopathologic examination and is often supported by immunohistochemical analysis. Once a diagnosis of EMPD is made, the patient must be risk-stratified and evaluated for an underlying malignancy.CONCLUSIONStandard of treatment is surgery, with data suggesting that Mohs micrographic surgery may have superior clinical outcomes and lower recurrence rates. Alternatives such as photodynamic therapy and topicals have been explored and may be appropriate in certain situations. Patients with EMPD generally have a good prognosis with a 5-year overall survival rate of 75% to 95%.

Original languageEnglish
Pages (from-to)305-311
Number of pages7
JournalDermatologic Surgery
Issue number3
StatePublished - Mar 1 2020


Dive into the research topics of 'Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis'. Together they form a unique fingerprint.

Cite this